Dr. Hammad Arshad, MD
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 20
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 187
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
PA license MD457667 -
Critical Care Medicine (Internal Medicine) Physician
PA license MD457667 -
Internal Medicine Physician
PA license MD457667
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Allegheny General Hospital Pittsburgh, PA
- Jefferson Hospital Jefferson Hills, PA
- West Penn Hospital Pittsburgh, PA
- Ahn Wexford Hospital Wexford, PA
- Grove City Medical Center Grove City, PA
Medical groups
- Allegheny Clinic (2,389 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 187
- Services billed
- 467
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 185 | 88 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 58 | 36 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 31 | 31 |
| Test to examine how well the lungs exchange gases | 30 | 30 |
| Test to determine lung volumes using sensors | 29 | 29 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 27 | 20 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 25 | 25 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 13 | 11 |
| Insertion of artery tube for blood sampling or infusion through skin | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 4 payments worth $285 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $145 |
|---|---|
| GlaxoSmithKline, LLC. | $114 |
| Haemonetics Corporation | $26.09 |
| Food and Beverage | $285 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.